ArticleChemistry & biodiversity2026
Phytochemical Profile, Antioxidant Activity, and Anti-Neuroinflammatory Effects of a Novel Dry Extract of Libidibia ferrea in Microglial Cells.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Libidibia ferrea is traditionally medicine used in northeastern Brazil; however, studies addressing chemically characterized extracts and pharmacological properties remain limited. This study investigated the chemical composition and anti-neuroinflammatory activity of a dry extract of L. ferrea (DELF) in lipopolysaccharide (LPS)-stimulated microglial cells, as well as its possible mechanisms of action. The extract was characterized using UPLC-ESI-QTOF-MS, and methyl gallate, the major compound, was quantified (38.15 µg/mg dry extract). Cytotoxicity in BV-2 cells was evaluated by the MTT assay. Antioxidant activity was assessed using free radical scavenging assays, while nitric oxide (NO) and IL-6 levels were determined using the Griess reaction and ELISA. iNOS expression was analyzed by western blotting. Eighteen compounds were identified, including phenolic acids, flavonoids, and hydroxy fatty acids. DELF also presented relevant mineral content. The extract (up to 100 µg/mL) and methyl gallate (up to 1.9 µg/mL) were non-cytotoxic. DELF at 100 µg/mL reduced nitrite release by 67% in LPS-stimulated cells and significantly reduced IL-6 production by 55%. DELF decreased NO levels without altering iNOS expression and exhibited antioxidant activity (90.16% DPPH, 83.6% superoxide, and ∼45% hydroxyl radical scavenging at 100 µg/mL). These findings highlight DELF as a promising source of bioactive compounds with potential anti-neuroinflammatory applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.